JPH0248000B2 - - Google Patents
Info
- Publication number
- JPH0248000B2 JPH0248000B2 JP58166200A JP16620083A JPH0248000B2 JP H0248000 B2 JPH0248000 B2 JP H0248000B2 JP 58166200 A JP58166200 A JP 58166200A JP 16620083 A JP16620083 A JP 16620083A JP H0248000 B2 JPH0248000 B2 JP H0248000B2
- Authority
- JP
- Japan
- Prior art keywords
- substance
- reaction reagent
- present
- administration
- mouse
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 230000000259 anti-tumor effect Effects 0.000 claims description 17
- 150000004676 glycans Polymers 0.000 claims description 13
- 239000013543 active substance Substances 0.000 claims description 10
- 238000006243 chemical reaction Methods 0.000 claims description 10
- 239000003153 chemical reaction reagent Substances 0.000 claims description 10
- 238000000034 method Methods 0.000 claims description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 7
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 5
- 239000007864 aqueous solution Substances 0.000 claims description 5
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 4
- 239000008103 glucose Substances 0.000 claims description 4
- 239000000243 solution Substances 0.000 claims description 4
- 238000000862 absorption spectrum Methods 0.000 claims description 3
- CLINFZQBXPTCNW-FVGYRXGTSA-N (2s)-2-amino-3-(1h-indol-3-yl)propanoic acid;sulfuric acid Chemical compound OS(O)(=O)=O.C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 CLINFZQBXPTCNW-FVGYRXGTSA-N 0.000 claims description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 2
- 239000002253 acid Substances 0.000 claims description 2
- 150000007513 acids Chemical class 0.000 claims description 2
- OHJMTUPIZMNBFR-UHFFFAOYSA-N biuret Chemical compound NC(=O)NC(N)=O OHJMTUPIZMNBFR-UHFFFAOYSA-N 0.000 claims description 2
- 238000000921 elemental analysis Methods 0.000 claims description 2
- 238000002523 gelfiltration Methods 0.000 claims description 2
- 238000002844 melting Methods 0.000 claims description 2
- 230000008018 melting Effects 0.000 claims description 2
- FEMOMIGRRWSMCU-UHFFFAOYSA-N ninhydrin Chemical compound C1=CC=C2C(=O)C(O)(O)C(=O)C2=C1 FEMOMIGRRWSMCU-UHFFFAOYSA-N 0.000 claims description 2
- 150000004804 polysaccharides Polymers 0.000 claims description 2
- MYKOKMFESWKQRX-UHFFFAOYSA-N 10h-anthracen-9-one;sulfuric acid Chemical compound OS(O)(=O)=O.C1=CC=C2C(=O)C3=CC=CC=C3CC2=C1 MYKOKMFESWKQRX-UHFFFAOYSA-N 0.000 claims 1
- 230000003287 optical effect Effects 0.000 claims 1
- 239000002904 solvent Substances 0.000 claims 1
- 239000000126 substance Substances 0.000 description 29
- 241000699666 Mus <mouse, genus> Species 0.000 description 17
- 230000000694 effects Effects 0.000 description 13
- 206010028980 Neoplasm Diseases 0.000 description 12
- 229920001282 polysaccharide Polymers 0.000 description 12
- 239000005017 polysaccharide Substances 0.000 description 12
- 238000002054 transplantation Methods 0.000 description 12
- 240000001080 Grifola frondosa Species 0.000 description 10
- 235000007710 Grifola frondosa Nutrition 0.000 description 10
- 230000005764 inhibitory process Effects 0.000 description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 8
- 241000699670 Mus sp. Species 0.000 description 8
- 230000004614 tumor growth Effects 0.000 description 8
- 238000002474 experimental method Methods 0.000 description 7
- 239000002244 precipitate Substances 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- 229920001503 Glucan Polymers 0.000 description 5
- 241001465754 Metazoa Species 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 4
- 235000019441 ethanol Nutrition 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 230000001093 anti-cancer Effects 0.000 description 3
- 229920002678 cellulose Polymers 0.000 description 3
- 239000001913 cellulose Substances 0.000 description 3
- 239000012153 distilled water Substances 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- 230000016784 immunoglobulin production Effects 0.000 description 3
- 238000001228 spectrum Methods 0.000 description 3
- 238000011282 treatment Methods 0.000 description 3
- UITMJPZVJJKFBV-ULAWRXDQSA-N (2r,3s,4r,5r)-3,5,6-trihydroxy-2,4-dimethoxyhexanal Chemical compound CO[C@@H](C=O)[C@@H](O)[C@H](OC)[C@H](O)CO UITMJPZVJJKFBV-ULAWRXDQSA-N 0.000 description 2
- CPALRJNELRTQTO-ULAWRXDQSA-N (2r,3s,4r,5r)-4,5,6-trihydroxy-2,3-dimethoxyhexanal Chemical compound CO[C@@H](C=O)[C@@H](OC)[C@H](O)[C@H](O)CO CPALRJNELRTQTO-ULAWRXDQSA-N 0.000 description 2
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 2
- NHBKXEKEPDILRR-UHFFFAOYSA-N 2,3-bis(butanoylsulfanyl)propyl butanoate Chemical compound CCCC(=O)OCC(SC(=O)CCC)CSC(=O)CCC NHBKXEKEPDILRR-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 241000186216 Corynebacterium Species 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 206010039491 Sarcoma Diseases 0.000 description 2
- 208000006268 Sarcoma 180 Diseases 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 238000000502 dialysis Methods 0.000 description 2
- 230000036737 immune function Effects 0.000 description 2
- 230000003308 immunostimulating effect Effects 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 230000002601 intratumoral effect Effects 0.000 description 2
- 239000003456 ion exchange resin Substances 0.000 description 2
- 229920003303 ion-exchange polymer Polymers 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 230000011987 methylation Effects 0.000 description 2
- 238000007069 methylation reaction Methods 0.000 description 2
- 230000000242 pagocytic effect Effects 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- LMHKDVPFDHNVFB-BZNPZCIMSA-N (2r,3s,4r,5r)-3,5-dihydroxy-2,4,6-trimethoxyhexanal Chemical compound COC[C@@H](O)[C@@H](OC)[C@H](O)[C@@H](OC)C=O LMHKDVPFDHNVFB-BZNPZCIMSA-N 0.000 description 1
- LMWNQPUYOLOJQP-UTINFBMNSA-N (2r,3s,4r,5r)-5-hydroxy-2,3,4,6-tetramethoxyhexanal Chemical compound COC[C@@H](O)[C@@H](OC)[C@H](OC)[C@@H](OC)C=O LMWNQPUYOLOJQP-UTINFBMNSA-N 0.000 description 1
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 1
- LMWNQPUYOLOJQP-UHFFFAOYSA-N 2,3,4,6-Me4-Glc Natural products COCC(O)C(OC)C(OC)C(OC)C=O LMWNQPUYOLOJQP-UHFFFAOYSA-N 0.000 description 1
- CPALRJNELRTQTO-UHFFFAOYSA-N 2,3-di-O-methyl-D-glucose Natural products COC(C=O)C(OC)C(O)C(O)CO CPALRJNELRTQTO-UHFFFAOYSA-N 0.000 description 1
- UTLUVTKMAWSZKV-UHFFFAOYSA-N 5-amino-6-(D-ribitylamino)-2,4(1H,3H)-pyrimidinedione Natural products COCC1OC(O)C(OC)C(O)C1OC UTLUVTKMAWSZKV-UHFFFAOYSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241000221198 Basidiomycota Species 0.000 description 1
- 241000037164 Collema parvum Species 0.000 description 1
- 241000019462 Colpodium versicolor Species 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 201000008808 Fibrosarcoma Diseases 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- HEMHJVSKTPXQMS-DYCDLGHISA-M Sodium hydroxide-d Chemical compound [Na+].[2H][O-] HEMHJVSKTPXQMS-DYCDLGHISA-M 0.000 description 1
- 235000019764 Soybean Meal Nutrition 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- SQYIWHJCOMWKNU-UHFFFAOYSA-N UNPD120476 Natural products COC1C(O)OC(CO)C(O)C1OC SQYIWHJCOMWKNU-UHFFFAOYSA-N 0.000 description 1
- AQWPITGEZPPXTJ-UHFFFAOYSA-N UNPD191049 Natural products COCC1OC(O)C(OC)C(OC)C1OC AQWPITGEZPPXTJ-UHFFFAOYSA-N 0.000 description 1
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- 230000007059 acute toxicity Effects 0.000 description 1
- 238000011047 acute toxicity test Methods 0.000 description 1
- -1 alditol acetate Chemical class 0.000 description 1
- 239000012670 alkaline solution Substances 0.000 description 1
- 230000000735 allogeneic effect Effects 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- RJGDLRCDCYRQOQ-UHFFFAOYSA-N anthrone Chemical compound C1=CC=C2C(=O)C3=CC=CC=C3CC2=C1 RJGDLRCDCYRQOQ-UHFFFAOYSA-N 0.000 description 1
- 210000000628 antibody-producing cell Anatomy 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 150000001879 copper Chemical class 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000005238 degreasing Methods 0.000 description 1
- 238000011033 desalting Methods 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 239000010200 folin Substances 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 238000004817 gas chromatography Methods 0.000 description 1
- 210000004013 groin Anatomy 0.000 description 1
- 230000009036 growth inhibition Effects 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 229960001438 immunostimulant agent Drugs 0.000 description 1
- 239000003022 immunostimulating agent Substances 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 239000002054 inoculum Substances 0.000 description 1
- 238000007912 intraperitoneal administration Methods 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- OQUKIQWCVTZJAF-UHFFFAOYSA-N phenol;sulfuric acid Chemical compound OS(O)(=O)=O.OC1=CC=CC=C1 OQUKIQWCVTZJAF-UHFFFAOYSA-N 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 229920001467 poly(styrenesulfonates) Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000012266 salt solution Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 235000011121 sodium hydroxide Nutrition 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000004455 soybean meal Substances 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 210000004988 splenocyte Anatomy 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000005748 tumor development Effects 0.000 description 1
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Plant Substances (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Peptides Or Proteins (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP58166200A JPS6058925A (ja) | 1983-09-09 | 1983-09-09 | 抗腫瘍活性物質 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP58166200A JPS6058925A (ja) | 1983-09-09 | 1983-09-09 | 抗腫瘍活性物質 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS6058925A JPS6058925A (ja) | 1985-04-05 |
| JPH0248000B2 true JPH0248000B2 (fr) | 1990-10-23 |
Family
ID=15826943
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP58166200A Granted JPS6058925A (ja) | 1983-09-09 | 1983-09-09 | 抗腫瘍活性物質 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS6058925A (fr) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2689244B2 (ja) * | 1993-04-30 | 1997-12-10 | 株式会社雪国まいたけ | 肝疾患改善剤の製造方法 |
| JP2732008B2 (ja) * | 1993-04-30 | 1998-03-25 | 株式会社雪国まいたけ | 育毛促進剤の製造方法 |
| JP2753935B2 (ja) * | 1993-04-30 | 1998-05-20 | 株式会社雪国まいたけ | 免疫抑制剤の製造方法 |
| JPH08119874A (ja) * | 1994-10-24 | 1996-05-14 | Takumi Sogabe | エイズウィルス・癌細胞の抑制剤の製造方法 |
| CN100432212C (zh) * | 2006-05-15 | 2008-11-12 | 徐泽平 | 灰树花菌株、培养方法及其应用 |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS59210901A (ja) * | 1983-05-17 | 1984-11-29 | Nippon Kinoko Kenkyusho | プロテオグルカン及びそれからなる抗ガン剤 |
-
1983
- 1983-09-09 JP JP58166200A patent/JPS6058925A/ja active Granted
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS59210901A (ja) * | 1983-05-17 | 1984-11-29 | Nippon Kinoko Kenkyusho | プロテオグルカン及びそれからなる抗ガン剤 |
Also Published As
| Publication number | Publication date |
|---|---|
| JPS6058925A (ja) | 1985-04-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5268467A (en) | Immunomodulatory polysaccharide fractions from Astragalus plants | |
| FI88109B (fi) | Foerfarande foer framstaellning av loesligt fosforylerat glukan | |
| SU730277A3 (ru) | Способ получени азотсодержащих полисахаридов, обладающих противоопухолевым действием | |
| EP0490995A1 (fr) | Procede de production de glucans solubles | |
| JPS6356881B2 (fr) | ||
| US4271151A (en) | Protein-bound polysaccharides | |
| FR2501232A1 (fr) | Polysaccharides doues d'activite anti-carcinogene et leur procede de production | |
| CH634855A5 (fr) | Procede de production de nouveaux derives de beta-1,3-glucanes. | |
| JP3444624B2 (ja) | 高分岐度β−グルカン、その製造法及び用途 | |
| SU704431A3 (ru) | Способ получени полисахаридов, обладающих противоопухолевым действием | |
| JP4032372B2 (ja) | 抗癌性物質 | |
| WO1992002231A1 (fr) | Agent anti-vih | |
| US4614733A (en) | Polysaccharides pharmaceutical compositions and the use thereof | |
| KR870001930B1 (ko) | 다당체 ron물질의 제조 방법 | |
| JPH0248000B2 (fr) | ||
| JPH02208301A (ja) | 米糠由来生理活性多糖ｒｏｎの製造法 | |
| JPH08301772A (ja) | 硫酸多糖類のカルシウム塩を含んで成る抗ウイルス剤 | |
| JP3129751B2 (ja) | ブナシメジ子実体熱水抽出物 | |
| KR870001931B1 (ko) | 다당체 rin 물질의 제조방법 | |
| JP2583183B2 (ja) | 生理活性を有するグリコーゲンの製法及び生理活性 | |
| JPS63307825A (ja) | 抗腫瘍剤及びその製法 | |
| SU961565A3 (ru) | Способ получени мукополисахаридов | |
| KR820000697B1 (ko) | 다당류의 제조방법 | |
| JPH0149280B2 (fr) | ||
| JPS6152806B2 (fr) |